Joseph Maria Gerardus Barbara Cals

This inventor holds 11 USPTO granted patents and 5 published patent applications, plus 7 CIPO patents and 8 EPO patents. Top assignees: Lead Pharma Holding B.v., Sanofi, Lead Pharma Cel Models IP B.v.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Maria Gerardus Barbara Cals. Retrieved from https://idiyas.com/inventor/joseph-maria-gerardus-barbara-cals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 5)

% Patents Active = 63.6

CIPO Patents = 7

EPO Patents = 8 (Patent Applications = 18)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

8 out of 8

Lead Pharma Holding B.v.

Lead Pharma Cel Models IP B.v.

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527774 - Estrogen-related receptor alpha modulators (2026-01-20),

2. 11299456 - ROR gamma (RORγ) modulators (2022-04-12),

3. 10556866 - ROR gamma (RORγ) modulators (2020-02-11),

4. 10428018 - ROR gamma (RORy) modulators (2019-10-01),

5. 10315996 - ROR gamma (RORγ) modulators (2019-06-11),

6. 10259782 - ROR gamma (RORγ) modulators (2019-04-16),

7. 10196350 - ROR gamma (RORγ) modulators (2019-02-05),

8. 10118895 - ROR gamma (RORγ) modulators (2018-11-06),

9. 9738600 - ROR gamma (RORγ) modulators (2017-08-22),

10. 8143246 - 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives (2012-03-27),

11. 7960560 - 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione (2011-06-14),

Title: Joseph Maria Gerardus Barbara Cals: Innovator in ROR Gamma Modulators

Introduction

Joseph Maria Gerardus Barbara Cals is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ROR gamma modulators. With a total of 10 patents to his name, Cals has established himself as a key figure in innovation.

Latest Patents

Cals' latest patents focus on ROR gamma (RORγ) modulators. These patents describe compounds that can be used as inhibitors of RORγ, which are beneficial for treating RORγ mediated diseases. The compounds are characterized by specific chemical formulas that include various alkyl and aryl groups, showcasing the complexity and potential of his inventions.

Career Highlights

Throughout his career, Cals has worked with prominent companies such as Lead Pharma Holding B.V. and Sanofi. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Cals has collaborated with notable colleagues, including Sander Bernardus Nabuurs and Vera De Kimpe. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Joseph Maria Gerardus Barbara Cals is a distinguished inventor whose work in ROR gamma modulators has the potential to significantly impact the treatment of various diseases. His extensive patent portfolio and collaborations highlight his commitment to innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.